Clover Health Investments, Corp. (NASDAQ:CLOV) Short Interest Update

Clover Health Investments, Corp. (NASDAQ:CLOV) saw a large decrease in short interest in the month of March. As of March 31st, there was short interest totalling 43,980,000 shares, a decrease of 7.5% from the March 15th total of 47,540,000 shares. Based on an average trading volume of 9,360,000 shares, the short-interest ratio is currently 4.7 days.

Insider Transactions at Clover Health Investments

In other Clover Health Investments news, Director Anna U. Loengard acquired 137,000 shares of the company’s stock in a transaction that occurred on Thursday, March 14th. The stock was acquired at an average price of $0.73 per share, for a total transaction of $100,010.00. Following the acquisition, the director now directly owns 538,841 shares in the company, valued at $393,353.93. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 21.82% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Clover Health Investments

A number of hedge funds have recently made changes to their positions in the stock. JPMorgan Chase & Co. lifted its stake in shares of Clover Health Investments by 10.2% during the 1st quarter. JPMorgan Chase & Co. now owns 77,719 shares of the company’s stock worth $276,000 after purchasing an additional 7,199 shares during the last quarter. Cambridge Investment Research Advisors Inc. increased its position in Clover Health Investments by 15.5% during the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 57,507 shares of the company’s stock valued at $204,000 after buying an additional 7,730 shares in the last quarter. Prelude Capital Management LLC increased its position in Clover Health Investments by 65.8% during the 1st quarter. Prelude Capital Management LLC now owns 19,732 shares of the company’s stock valued at $70,000 after buying an additional 7,832 shares in the last quarter. The Manufacturers Life Insurance Company increased its position in Clover Health Investments by 6.0% during the 4th quarter. The Manufacturers Life Insurance Company now owns 151,424 shares of the company’s stock valued at $141,000 after buying an additional 8,637 shares in the last quarter. Finally, Lazard Asset Management LLC acquired a new position in Clover Health Investments during the 1st quarter valued at about $35,000. 19.77% of the stock is currently owned by hedge funds and other institutional investors.

Clover Health Investments Stock Performance

Shares of Clover Health Investments stock traded down $0.01 during midday trading on Tuesday, reaching $0.63. 5,340,267 shares of the company’s stock traded hands, compared to its average volume of 9,232,332. The company has a market cap of $309.56 million, a PE ratio of -1.39 and a beta of 1.84. The stock has a 50 day moving average of $0.83 and a 200-day moving average of $0.93. Clover Health Investments has a 12 month low of $0.61 and a 12 month high of $1.63.

Clover Health Investments (NASDAQ:CLOV) last announced its quarterly earnings data on Tuesday, March 12th. The company reported ($0.12) EPS for the quarter, beating the consensus estimate of ($0.18) by $0.06. The company had revenue of $510.25 million for the quarter, compared to the consensus estimate of $491.20 million. Clover Health Investments had a negative return on equity of 62.58% and a negative net margin of 10.49%. On average, equities analysts anticipate that Clover Health Investments will post -0.2 earnings per share for the current fiscal year.

Clover Health Investments Company Profile

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.